AMNIO-MAXX®
Dual Layer Amnion Allograft
Advanced Dual Layer Amnio Patch for Surgical Applications
Product Overview
Amnio-Maxx® is a dual layered, dehydrated, amniotic tissue membrane graft derived from placental tissue. This product is used for chronic, non-healing wounds such as diabetic foot ulcers and venous leg ulcers or soft tissue defects.
Application and Features
Amnio-Maxx® features a dual-layer structure that offers twice the growth factor content to support tissue regeneration. The thicker graft design enhances handling during robotic and laparoscopic procedures. Its chorion-free, immune-privileged profile minimizes the risk of adverse reactions, while the dual-sided configuration allows for easy placement without orientation restrictions.
Additionally, Amnio-Maxx® provides exceptional biomechanical integrity – offering greater tensile strength, improved shape manipulation, and slower resorption in vivo1 – making it an ideal choice for demanding surgical environments.
Support Healing with Amnio-Maxx® Dual Layer Graft
Non-Immunogenic
Immune privileged to reduce the risk of rejection or inflammation.
SUPPORTS A HEALING ENVIRONMENT
Cleansed to reduce bioburden and promote a safer healing space.
Contains growth factors shown to help control inflammation.3
Tissue regeneration/remodeling
Delivers key proteins and growth factors that promote healing and regeneration.
Anti-adhesive/anti-scarring
Acts as a barrier to reduce scar tissue formation after surgery.
| Product Code | Description | Size |
|---|---|---|
|
AMN-22 |
Amnio-Maxx® Dual Layer Amnion Allograft (Q4239) |
2×2 cm |
|
AMN-23 |
Amnio-Maxx® Dual Layer Amnion Allograft (Q4239) |
2×3 cm |
|
AMN-24 |
Amnio-Maxx® Dual Layer Amnion Allograft (Q4239) |
2×4 cm |
|
AMN-44 |
Amnio-Maxx® Dual Layer Amnion Allograft (Q4239) |
4×4 cm |
|
AMN-46 |
Amnio-Maxx® Dual Layer Amnion Allograft (Q4239) |
4×6 cm |
|
AMN-48 |
Amnio-Maxx® Dual Layer Amnion Allograft (Q4239) |
4×8 cm |
The placenta contains growth factors and proteins that stimulate the body's own healing mechanism, reducing pain, inammation, and scar tissue 4
- Platelet Derived Growth Factor (PDGF) A & B
- Transforming Growth Factor beta (TGFβ)
- Epidermal Growth Factor (EGF)
- Collagen Types I, III, IV, V, VII
- Fibronectin
- Hyaluronic Acid (HA)
- Vascular Endothelial Growth Factor (VEGF)
- Fibroblast Growth Factor (FGF)
- Tissue Inhibitors of Metalloproteinases (TIMPs)
- Laminin
- Proteoglycans
Reference:
- Spoerl, et al. Ophthalmic Res. 2004;36(2):71-7
- Martin, et al. Encyclopedia of Reproduction, 2018;3:387-398.
- Sinno, Prakash. Plast Surg Int. 2013:146764.
- Mamede, et al. Cell Tissue Res. 2012, 349:447–458.
Documents and Downloads
Check out our detailed product information to learn how Amnio-Maxx® utilizes dual-layer amniotic membrane technology to support surgical healing and reduce scar tissue formation.
Product Overview
Join Us in Transforming Wound Care!
We are excited to embark on this journey and we invite wound care professionals and providers alike to join us. Together, we can make a difference in the lives of patients and create a brighter future. Contact us today to learn more about how Total Ancillary can help.
